Test Your Knowledge: A Myasthenia Gravis Quiz for Clinicians
Reviewed by: HU Medical Review Board | Last reviewed: August 2026 | Last updated: August 2026
Myasthenia gravis (MG) management has changed quickly, with new targeted therapies, new treatment-specific safety considerations, and a path to diagnosis that is often longer than it should be. This quiz checks your working knowledge across treatment mechanisms of action, the diagnostic journey, diagnostic work-up, disease monitoring, and drug safety. Review each question below to test your clinical decision-making.
Clinical Challenge
Which mechanism of action best characterizes the terminal complement (C5) inhibitors used in acetylcholine receptor (AChR) antibody-positive generalized MG (gMG)?
Clinical Challenge
When acetylcholine receptor (AChR) antibodies are negative in suspected gMG, antibodies against which target should be tested next?
Clinical Challenge
Which statement about the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale is correct?
Clinical Challenge
After a diagnosis of myasthenia gravis is confirmed, which evaluation is recommended for all patients with newly diagnosed MG?
Clinical Challenge
A patient presents with isolated ptosis and diplopia consistent with ocular myasthenia gravis. Which statement about prognosis is most accurate?